HCL Group and UpLink Announce Winners of ‘Tackling Water Pollution Challenge’ Under the Aquapreneur Innovation Initiative
21.1.2025 17:18:00 EET | Business Wire | Press release
HCL Group, a leading global conglomerate, and UpLink, the World Economic Forum’s early-stage innovation initiative, have announced the winners of the 'Tackling Water Pollution Challenge,’ the third in a series of five challenges under the five-year, CHF 15 million Aquapreneur Innovation Initiative launched by HCL Group. The announcement marks a significant step in the ongoing mission to address global water challenges through groundbreaking innovation and entrepreneurship.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250121986084/en/
Roshni Nadar Malhotra, Chairperson of HCL Group, announces the winners of ‘Tackling Water Pollution Challenge’ under the Aquapreneur Innovation Initiative in Davos. (Photo: Business Wire)
After evaluating over 270 submissions from around 60 nations, 10 Aquapreneurs from 9 countries were chosen for their innovative solutions in the freshwater sector. This year’s winners, termed ‘UpLink Top Innovators and Aquapreneurs’, reflect a diverse set of expertise demonstrating the transformative potential of innovation in tackling water pollution worldwide. The winners will share financial award from a pool of CHF 1.75 million, enabling them to scale their initiatives and amplify their impact. In addition to funding, the winners will also gain access to exclusive resources, mentorship, and global networks provided by HCL Group and UpLink.
The Tackling Water Pollution Challenge was dedicated to addressing freshwater issues worldwide, with special focus on combating water pollution. Solutions presented by winners included cutting-edge advancements in filtration systems, wastewater treatment, industrial water reuse, and water quality monitoring technologies.
Highlighting the role of Aquapreneur Innovation Initiative in combating challenges related to freshwater, Roshni Nadar Malhotra,Chairperson of HCL Group, said: “Water scarcity and pollution are existential threats to humanity and biodiversity. The Aquapreneur Innovation Initiative launched a couple of years ago aims to discover and support the most innovative start-ups and scale-ups tackling the world’s most pressing water issues. The 20 pioneering start-ups, winners of the previous two years, have collectively gone on to achieve immense success. In 2024 alone, they helped save over 12 billion litres of water, equivalent to Switzerland’s entire water footprint each year. They also treated 3 billion litres of wastewater. The Grant provided by HCL enabled them to expand to new markets, deploy pilot projects, increase customer count, and scale-up production and operations. These 20 start-ups have raised US$70 million in funding since joining the Initiative. So, congratulations to all ten of this year’s winners. I’m already looking forward to returning to Davos next year to share their successes!”
Added Olivier Schwab, Managing Director of the World Economic Forum, “As water challenges grow more urgent, HCL Group and UpLink’s continued commitment underscores the need for collaborative innovation to safeguard freshwater ecosystems. The initiative is not just driving immediate solutions, investment and multistakeholder partnerships —it is paving the way for a sustainable future where clean, accessible water is a reality for all. By supporting bold, scalable solutions, we are making a critical contribution to addressing one of the most significant global challenges of our time. The collaboration between HCL Group and UpLink continues to set a global benchmark for how innovation can drive large-scale, lasting change.”
Water pollution is a global challenge, with about 80% of the world's untreated wastewater being released into rivers, lakes, and oceans. This leads to 485,000 premature deaths every year worldwide and costs the global economy $260 billion annually. The challenge of water pollution intensifies as countries industrialize, with chemical contamination of freshwater sources being prominent across industrial economies. This includes the rise of microplastics and PFAS (Per- and polyfluorinated alkyl substances), also known as the Forever Chemicals in water supplies, risking public health.
The 2025 Tackling Water Pollution Challenge Winners
- Aquagga, United States of America, focuses on innovative PFAS destruction using its Hydrothermal Alkaline Treatment (HALT) technology for environmental remediation and wastewater treatment.
- Digital Paani, India, focuses on enhancing operational excellence in water treatment, addressing water scarcity and pollution through scalable solutions in under-resourced areas.
- Fluidion, France, advances water intelligence with innovative sampling solutions that monitor pollution and water quality across urban, natural, and industrial environments.
- FREDsense, Canada, provides in-field lab-based water quality testing solutions, empowering utilities and environmental consultants with real-time, accurate data for effective water management.
- Fungi Life, Colombia, uses fungal biotechnology to create sustainable ingredients, aiming for net-zero emissions by revalorizing agro-industrial waste for environmental sustainability.
- Mimbly, Sweden, optimizes water resources in the laundry industry through innovative recycling and filtration solutions, promoting sustainability with advanced water-saving technologies.
- Oxyle, Switzerland, offers an economical, sustainable solution to PFAS contamination by completely eliminating PFAS from water, empowering industrial and environmental remediation companies to tackle contamination effectively.
- SENTRY, Canada, is a biological activity and water quality monitoring platform that uses unique bio-electrode sensor technology for real-time microbial performance monitoring in wastewater treatment systems.
- Syrinx, Australia, offers innovative water treatment solutions with its nature-based 'Wetland-in-a-Box'® (EnPhytoBox), addressing water pollution and boosting climate resilience, especially in agriculture.
- WASE, United Kingdom, treats industrial wastewater onsite, helping customers comply with regulations, maximize bioenergy generation, and decarbonize thermal energy demands through sustainable, economically viable solutions.
In addition to the financial awards, the winners will have the opportunity to participate in events and projects led by the World Economic Forum and its partners. These opportunities will provide invaluable support to scale their ventures, ensuring sustainable and impactful solutions for water challenges.
Since its inception, the Aquapreneur Innovation Initiative has made notable progress in addressing global freshwater challenges. This funding has enabled winners to innovate, scale production, and expand into new markets. The initiative has also driven progress in water conservation, wastewater treatment, greenhouse gas emission reductions, and job creation. To date, top innovators have cumulatively raised over $70 million in funding to scale their innovations.
HCL Group and UpLink’s ongoing collaboration underscores their shared commitment to sustainability and innovation, paving the way for a future where freshwater resources are managed responsibly and effectively.
Notes to the editor
About UpLink
UpLink is the World Economic Forum’s early-stage innovation initiative that builds ecosystems that enable purpose-driven, early-stage entrepreneurs to scale their business for the markets and economies that are essential for a net-zero, nature-positive, equitable future.
Sourcing innovations through a competition framework known as innovation challenges, UpLink has run more than 50 challenges to date and selected over 500 early-stage entrepreneurs with innovative solutions across critical SDG areas including freshwater, health, food, ocean, plastics, education, climate and more.
For more information, visit https://uplink.weforum.org
About HCL Group:
Founded in 1976 as one of India’s original IT garage start-ups, HCL Group is a pioneer of modern computing with many firsts to its credit, including the introduction of the 8-bit microprocessor-based computer in 1978 well before its global peers. Today, the HCL Group has a presence across varied sectors that include technology, healthcare and talent management solutions and comprises three companies – HCL Infosystems, HCLTech and HCL Healthcare. The enterprise generates annual revenues of over US$13.8 billion with 220,000 employees operating across 60 countries. For further information, visit www.hcl.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250121986084/en/
Contacts
For further information, please contact:
Shruti Saxena: shruti-saxena@hcl.com (9654356487)
Alisha Bisherwal: Alisha.a@hcl.com (8447821231)
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 15:00:00 EEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure26.5.2026 15:00:00 EEST | Press release
ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser System to deliver an incision-free, image-guided femtosecond laser treatment designed to create precise channels through the trabecular meshwork to restore aqueous outflow and reduce intraocular pressure in patients with open-angle glaucoma. “Centre for Sight has always been committed to bringing meaningful innovation to patients through technologies that advance precision, safety, and the overall treatment experience,” said Sheraz Daya, MD, Medical Director and Founder of Centre for Sight. “We are proud to be the first center globally
BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events26.5.2026 15:00:00 EEST | Press release
BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research questions and needs, including preparation, handling, and utilization of the high-quality tissues and cells needed for microphysiological systems (MPS), as well as conducting ADME studies and bioanalysis. BioIVT offers an extensive range of control and disease state biospecimens, including SPHEROID CERTIFIED™ Hepatocytes as well as advanced HEPATOPAC® co-cultures and HEPATOMUNE® tri-cultures. Additionally, Christian Smith, Scientist I, R&D at BioIVT will present a poster titled "Therapeutic Reversal of Established Steatosis Usin
IHS Towers Publishes 2025 Sustainability Report26.5.2026 13:34:00 EEST | Press release
IHS Holding Limited (NYSE: IHS) (“IHS Towers”) group, one of the largest independent owners, operators, and developers of shared communications infrastructure in the world by tower count, has today published its 2025 Sustainability Report. The report covers sustainability activities from January 1, 2025 to December 31, 2025 and demonstrates IHS Towers’ continued commitment to its stakeholders, including, but not limited to, its employees, customers, suppliers, local communities, regulators, governments and shareholders. IHS Towers’ vision is to help create a connected world, where mobile connectivity promotes continued economic growth and social development. The communications infrastructure it provides is vital to enabling that connectivity. In 2025, IHS Towers continued to advance its four-pillar sustainability strategy – focusing on ethics and governance, environment and climate change, education and economic growth, our people and communities – as detailed in this report. Sam Darwi
Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 202626.5.2026 13:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Jefferies Global Healthcare Conference on June 3, 2026 and will participate in a fireside chat at 12:45pm ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational CO
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom